Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Tofacitinib on coagulation and platelet function, and its role in thromboembolic events
2024-518434-83-01Phase 4Completed
- Sponsor
- Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tofacitinib in autoimmune colitis (4 arms), sponsored by Fundación de Investigación Biomédica del Hospital Universitario de La Princesa. Primary endpoint: Platelet activation status and aggregation. Started Nov 2024; status: completed.
02
Drugs
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2024-518434-83-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518434-83-01.